(SeaPRwire) –   My path into the medical field began with the loss of my grandfather to cancer. I recall him dropping me off at school one morning in the sixth grade, only for him to be gone by the time I returned. Shortly thereafter, I purchased an oncology textbook. Science had always been my passion, and I believed it held the keys to finding answers.

Years later, as a physician, I was still searching. My hospital served as a national hub for rare pediatric diseases, 95% of which lacked cures. Daily, I was confronted by the limitations of medicine in explaining my patients’ conditions—the invisible cellular malfunctions and the symptoms that defied explanation.

We have all experienced this sense of grief and helplessness. Loved ones are misdiagnosed, and we are prescribed ineffective treatments. It is difficult to even discuss conditions like Alzheimer’s or Parkinson’s, where scientific progress has stalled for decades and hope feels distant.

However, I am convinced this can change—not in half a century, but much sooner—if the scientific community acts with urgency and unity to harness the potential of AI in human health.

We are already witnessing glimpses of this potential. For instance, researchers have developed advanced AI models capable of creating novel proteins to target cancer cells and neutralize pathogens. These models succeed because they are trained on vast datasets, gaining a profound understanding of how proteins fold and function. This same technology could eventually model entire cells, tissues, organs, and perhaps the entirety of human biology.

Given this immense potential and the rapid advancements currently underway, now is the time for leaders in technology, research, and philanthropy to establish the groundwork for a new era of discovery and medical breakthroughs. No single entity can achieve this alone. This is why we must unite the global community to create an open data foundation for AI-driven biology. It is also why my organization, Biohub, is launching the Virtual Biology Initiative.

Sophisticated cell models could revolutionize the discovery process. For centuries, scientific research has progressed by simplifying complex questions. We eliminate variables, reduce complexity, and restrict our focus to processes that fit within laboratory testing and grant timelines. Consequently, we are left with knowledge that fails to fully represent our biology.

AI models are not bound by these limitations, offering the scientific community a way to tackle the most pressing and difficult questions in human health. If AI can simulate and comprehend the immune system, we could engineer therapies to preemptively stop diseases like cancer, neurodegeneration, or metabolic disorders. The potential for new cures would be limited only by the scale of these models.

Yet, this presents the field’s greatest hurdle. Before AI can simulate biology, it must be able to observe it, and most cellular activity remains unmeasured and unseen. Protein models are typically trained on protein databases, and genomic models on genomic databases. We require an equivalent model for cells, supported by a massive, public repository that captures every type, behavior, and state cells exhibit within the human body and other organisms.

To achieve this, the scientific community must collaborate on an unprecedented scale.

Over the last decade, global research institutions have worked together to advance our understanding of cellular biology, supporting large-scale data projects like benchmark cell maps for humans and other species. We have also established cellular imaging repositories and created one of the world’s largest single-cell databases. Last year, we united public and private entities to launch the Billion Cells Project network, which is producing a massive open-source biological dataset.

The Virtual Biology Initiative will build upon this foundation. To catalyze a coordinated global effort, it begins with a $100 million commitment to fund data generation across the scientific community. Biohub is partnering with institutions such as the Allen Institute, Arc Institute, Broad Institute, and Wellcome Sanger Institute, alongside consortia like the Human Cell Atlas and the Human Protein Atlas. NVIDIA is also partnering on this initiative, and Renaissance Philanthropy will join to help secure funding.

Within Biohub, we will continue to develop frontier technologies for measuring cells. Imaging is a primary focus of this $400 million commitment: our roadmap includes microscopy to observe millions to billions of cells in living organisms, and cryo-electron tomography to resolve atomic-level cellular details. We also aim to advance cell and tissue engineering, enabling researchers to conduct new types of experiments and measure biological processes currently beyond our reach.

If you have the resources to support biological research, I urge you to join this effort. I am confident that AI models will resolve mysteries in human health that have eluded us for a century. We will reach these answers faster by working together.

Open-source technology is fostering a more collaborative research model—one that brings together multidisciplinary teams to solve challenges no single institution can tackle alone. Experts have discussed the promise of personalized medicine for decades. Through this initiative and the AI models powered by this data, I believe we can finally make that promise a reality for patients everywhere.

Whether they realize it or not, millions of people—sick patients, concerned families, and those who have yet to begin their search—are counting on our success.